Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

NCT07154511 is registered in ClinicalTrials.gov with Prabesh Kanel as lead sponsor.

NCT NCT07154511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07154511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Lead sponsor
Prabesh Kanel
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 7, 2025
Completion date
May 31, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, parkinson disease dementia